Insulin regulates lipolysis and fat mass by upregulating growth/differentiation factor 3 in adipose tissue macrophages

Y Bu, K Okunishi, S Yogosawa, K Mizuno… - Diabetes, 2018 - Am Diabetes Assoc
Y Bu, K Okunishi, S Yogosawa, K Mizuno, MJ Irudayam, CW Brown, T Izumi
Diabetes, 2018Am Diabetes Assoc
Previous genetic studies in mice have shown that functional loss of activin receptor–like
kinase 7 (ALK7), a type I transforming growth factor-β receptor, increases lipolysis to resist
fat accumulation in adipocytes. Although growth/differentiation factor 3 (GDF3) has been
suggested to function as a ligand of ALK7 under nutrient-excess conditions, it is unknown
how GDF3 production is regulated. Here, we show that a physiologically low level of insulin
converts CD11c− adipose tissue macrophages (ATMs) into GDF3-producing CD11c+ …
Previous genetic studies in mice have shown that functional loss of activin receptor–like kinase 7 (ALK7), a type I transforming growth factor-β receptor, increases lipolysis to resist fat accumulation in adipocytes. Although growth/differentiation factor 3 (GDF3) has been suggested to function as a ligand of ALK7 under nutrient-excess conditions, it is unknown how GDF3 production is regulated. Here, we show that a physiologically low level of insulin converts CD11c adipose tissue macrophages (ATMs) into GDF3-producing CD11c+ macrophages ex vivo and directs ALK7-dependent accumulation of fat in vivo. Depletion of ATMs by clodronate upregulates adipose lipases and reduces fat mass in ALK7-intact obese mice, but not in their ALK7-deficient counterparts. Furthermore, depletion of ATMs or transplantation of GDF3-deficient bone marrow negates the in vivo effects of insulin on both lipolysis and fat accumulation in ALK7-intact mice. The GDF3-ALK7 axis between ATMs and adipocytes represents a previously unrecognized mechanism by which insulin regulates both fat metabolism and mass.
Am Diabetes Assoc